skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > organooxygen compound > ester > carboxylic ester > lactone > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > organooxygen compound > carbonyl compound > carboxylic ester > lactone > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
organooxygen compound > ester > lactone > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > organooxygen compound > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > peptide > depsipeptide > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > peptide > depsipeptide > cyclodepsipeptide > n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide

Preferred term

n-[(2s,3r)-1-[[2-[[(2s)-1-[[(3s,6s,9s,12s)-3,6-bis(3-amino-3-oxopropyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C40H65N11O12

inchi

  • InChI=1S/C40H65N11O12/c1-22(2)11-9-7-5-6-8-10-12-32(55)51-34(24(4)52)39(61)44-19-33(56)46-23(3)35(57)50-29-20-63-40(62)27(14-16-31(42)54)48-36(58)26(13-15-30(41)53)47-37(59)28(49-38(29)60)17-25-18-43-21-45-25/h18,21-24,26-29,34,52H,5-17,19-20H2,1-4H3,(H2,41,53)(H2,42,54)(H,43,45)(H,44,61)(H,46,56)(H,47,59)(H,48,58)(H,49,60)(H,50,57)(H,51,55)/t23-,24+,26-,27-,28-,29-,34-/m0/s1

inchikey

  • RAZVMBLMUAZRSF-VCJCTMQHSA-N

mass

  • 892.025

monoisotopicmass

  • 891.48142

smiles

  • O=C1OC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CCCCCCCCC(C)C)[C@H](O)C)C)C(=O)N[C@@H](CC=2NC=NC2)C(N[C@H](C(N[C@H]1CCC(=O)N)=O)CCC(=O)N)=O

subset

  • 2_STAR

synonym EXACT

  • N-[(2S,3R)-1-[[2-[[(2S)-1-[[(3S,6S,9S,12S)-3,6-bis(3-amino-3-oxopropyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]-10-methylundecanamide

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:200921

Download this concept:

RDF/XML TURTLE JSON-LD